Khan W, Khan N, Tembhre M, Malik Z, Ansari M, Mishra A
Mol Divers. 2025; .
PMID: 40085404
DOI: 10.1007/s11030-025-11163-0.
Nurrohman A, Suwito H, Puspaningsih N, Haq K
RSC Adv. 2024; 14(52):39017-39026.
PMID: 39659606
PMC: 11629752.
DOI: 10.1039/d4ra07713j.
Asif Raza M, Ashraf M
Arch Microbiol. 2024; 206(12):458.
PMID: 39499323
DOI: 10.1007/s00203-024-04181-3.
Harrison R, Mubareka S, Papenburg J, Schober T, Allen U, Hatchette T
J Assoc Med Microbiol Infect Dis Can. 2023; 8(3):176-185.
PMID: 38058499
PMC: 10697102.
DOI: 10.3138/jammi-2023-07-12.
Bai X, Xi S, Chen G, Fan X, Wang K, Li Y
BMC Infect Dis. 2023; 23(1):585.
PMID: 37674112
PMC: 10483848.
DOI: 10.1186/s12879-023-08570-9.
Influenza antivirals and their role in pandemic preparedness.
Jones J, Yen H, Adams P, Armstrong K, Govorkova E
Antiviral Res. 2022; 210:105499.
PMID: 36567025
PMC: 9852030.
DOI: 10.1016/j.antiviral.2022.105499.
The effect of statins on the prevalence and mortality of influenza virus infection: a systematic review and meta-analysis.
Vahedian-Azimi A, Mannarino M, Shojaie S, Rahimibashar F, Galeh H, Banach M
Arch Med Sci. 2022; 18(6):1513-1524.
PMID: 36457966
PMC: 9710257.
DOI: 10.5114/aoms/149633.
Use of antiviral drugs for seasonal influenza: Foundation document for practitioners-Update 2019.
Aoki F, Allen U, Mubareka S, Papenburg J, Stiver H, Evans G
J Assoc Med Microbiol Infect Dis Can. 2022; 4(2):60-82.
PMID: 36337743
PMC: 9602959.
DOI: 10.3138/jammi.2019.02.08.
Protein Disulfide Isomerase A3 Regulates Influenza Neuraminidase Activity and Influenza Burden in the Lung.
Chamberlain N, Ruban M, Mark Z, Bruno S, Kumar A, Chandrasekaran R
Int J Mol Sci. 2022; 23(3).
PMID: 35162999
PMC: 8834910.
DOI: 10.3390/ijms23031078.
Anti-influenza virus activity of the elenolic acid rich olive leaf ( L.) extract Isenolic.
Salamanca A, Almodovar P, Jarama I, Gonzalez-Hedstrom D, Prodanov M, Inarejos-Garcia A
Antivir Chem Chemother. 2021; 29:20402066211063391.
PMID: 34839747
PMC: 8641117.
DOI: 10.1177/20402066211063391.
Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance.
Bai Y, Jones J, Wong S, Zanin M
Viruses. 2021; 13(4).
PMID: 33917376
PMC: 8067422.
DOI: 10.3390/v13040624.
Effects of Different Drug Combinations in Immunodeficient Mice Infected with an Influenza A/H3N2 Virus.
Mhamdi Z, Fausther-Bovendo H, Uyar O, Carbonneau J, Venable M, Abed Y
Microorganisms. 2020; 8(12).
PMID: 33322333
PMC: 7764069.
DOI: 10.3390/microorganisms8121968.
Screening for Anti-Influenza Actives of Prefractionated Traditional Chinese Medicines.
Kang Q, Wang Y, Cui Q, Gong L, Yang Y, Jiang H
Evid Based Complement Alternat Med. 2020; 2020:4979850.
PMID: 33123207
PMC: 7584957.
DOI: 10.1155/2020/4979850.
Decreased Hospital Length of Stay With Early Administration of Oseltamivir in Patients Hospitalized With Influenza.
Dou L, Reynolds D, Wallace L, OHoro J, Kashyap R, Gajic O
Mayo Clin Proc Innov Qual Outcomes. 2020; 4(2):176-182.
PMID: 32280928
PMC: 7139986.
DOI: 10.1016/j.mayocpiqo.2019.12.005.
Pathogenesis of pandemic H1N1 2009 influenza virus infection and the implication on management.
To K, Li I, Hung I, Cheng V, Yuen K
Front Med China. 2020; 4(2):147-156.
PMID: 32214991
PMC: 7088550.
DOI: 10.1007/s11684-010-0030-9.
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.
Uyeki T, Bernstein H, Bradley J, Englund J, File T, Fry A
Clin Infect Dis. 2018; 68(6):e1-e47.
PMID: 30566567
PMC: 6653685.
DOI: 10.1093/cid/ciy866.
Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan.
Chong Y, Matsumoto S, Kang D, Ikematsu H
Influenza Other Respir Viruses. 2018; 13(2):115-122.
PMID: 30548432
PMC: 6379637.
DOI: 10.1111/irv.12624.
Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus.
Baz M, Carbonneau J, Rheaume C, Cavanagh M, Boivin G
Viruses. 2018; 10(11).
PMID: 30400276
PMC: 6266789.
DOI: 10.3390/v10110610.
Replacement of neuraminidase inhibitor-susceptible influenza A(H1N1) with resistant phenotype in 2008 and circulation of susceptible influenza A and B viruses during 2009-2013, South Africa.
Treurnicht F, Buys A, Tempia S, Seleka M, Cohen A, Walaza S
Influenza Other Respir Viruses. 2018; 13(1):54-63.
PMID: 30218485
PMC: 6304311.
DOI: 10.1111/irv.12611.
Magnetic beads-based neuraminidase enzyme microreactor as a drug discovery tool for screening inhibitors from compound libraries and fishing ligands from natural products.
Zhao Y, Wang L, Luo S, Wang Q, Moaddel R, Zhang T
J Chromatogr A. 2018; 1568:123-130.
PMID: 30005943
PMC: 6261295.
DOI: 10.1016/j.chroma.2018.07.031.
